These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 1718319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R.
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [Abstract] [Full Text] [Related]

  • 3. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A, Klenerman P.
    Science; 2002 May 24; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract] [Full Text] [Related]

  • 4. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H, Miwa K, Shiga H, Moore YI, Oka S, Iwamoto A, Kaneko Y, Takiguchi M.
    J Immunol; 1997 May 15; 158(10):5026-34. PubMed ID: 9144523
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic T-cell epitopes in HIV/SIV infection.
    Venet A, Walker BD.
    AIDS; 1993 May 15; 7 Suppl 1():S117-26. PubMed ID: 7689848
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL, Walker BD.
    Nat Med; 2003 Jul 15; 9(7):861-6. PubMed ID: 12835706
    [Abstract] [Full Text] [Related]

  • 8. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD.
    AIDS Res Hum Retroviruses; 1994 Jul 15; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract] [Full Text] [Related]

  • 9. Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
    Goulder PJ, Edwards A, Phillips RE, McMichael AJ.
    AIDS; 1997 Jun 15; 11(7):930-2. PubMed ID: 9189221
    [No Abstract] [Full Text] [Related]

  • 10. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA.
    Biotechnol Ther; 1991 Jun 15; 2(1-2):123-35. PubMed ID: 1726961
    [Abstract] [Full Text] [Related]

  • 11. Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.
    Li F, Malhotra U, Gilbert PB, Hawkins NR, Duerr AC, McElrath JM, Corey L, Self SG.
    Vaccine; 2006 Nov 17; 24(47-48):6893-904. PubMed ID: 16890329
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV.
    Gotch F, Nixon D, Gallimore A, McAdam S, McMichael A.
    J Med Primatol; 1993 Nov 17; 22(2-3):119-23. PubMed ID: 7692055
    [Abstract] [Full Text] [Related]

  • 13. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H.
    Behring Inst Mitt; 1994 Dec 17; (95):23-34. PubMed ID: 7755506
    [Abstract] [Full Text] [Related]

  • 14. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
    Haynes BF, Yasutomi Y, Torres JV, Gardner MB, Langlios AJ, Bolognesi DP, Matthews TJ, Scearce RM, Jones DM, Moody MA.
    Trans Assoc Am Physicians; 1993 Dec 17; 106():33-41. PubMed ID: 8036743
    [No Abstract] [Full Text] [Related]

  • 15. CD4+ T cell epitopes in HIV-1 proteins.
    Siliciano RF.
    Chem Immunol; 1993 Dec 17; 56():127-49. PubMed ID: 7680866
    [No Abstract] [Full Text] [Related]

  • 16. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M, Tang S, Therrien D, Kløverpris H, Vinner L, Kronborg G, Gerstoft J, Corbet S, Fomsgaard A.
    APMIS; 2007 Jun 17; 115(6):757-68. PubMed ID: 17550385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Role of HLA in HIV-1 infection].
    Takiguchi M.
    Uirusu; 2000 Jun 17; 50(1):47-55. PubMed ID: 10998978
    [No Abstract] [Full Text] [Related]

  • 19. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T.
    Curr Opin Mol Ther; 2003 Feb 17; 5(1):25-32. PubMed ID: 12669467
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.